Gynecological radiotherapy patients describe consent without adequate preparation for treatment and side effects

In 27 interviews, patients described rushed radiotherapy decisions, limited discussion of declining treatment, and insufficient preparation for treatment-related effects.

KEY POINTS

  • This qualitative study was conducted within the UK GRACE (Gynae Radiotherapy Consent Enhancement) research program, using 27 in-depth semi-structured interviews with patients who had experienced decisions about curative or adjuvant gynecological radiotherapy. Participants were recruited through five NHS sites across England, Wales, and Scotland, with interviews conducted between July 2025 and April 2026. Diagnoses included 12 endometrial/uterine, nine cervical, four vulvar, and two vaginal cancers.
  • The analysis identified three central themes: decisions under duress, consent to treatment as the default, and the difference between being informed and being prepared. Interviews lasted 38–174 minutes and explored treatment decisions, information provision, consent, treatment experiences, and adverse effects. Patient representatives participated directly in the collaborative thematic analysis. The study was designed to understand lived experiences rather than measure treatment satisfaction or consent quality using numerical scales.
  • Patients frequently described making treatment decisions under considerable emotional pressure. Fear of cancer recurrence or death often dominated decision-making, reducing their perceived ability to process information and consider alternatives. Participants described a rapid progression from diagnosis to multidisciplinary treatment recommendations and consent appointments. Signing consent could create the impression that a decision was final, even when patients technically retained the right to reconsider.
  • The option of declining radiotherapy was often absent from consent discussions. Most participants reported that clinicians had not explicitly explored what would happen if treatment was refused. Only one participant described receiving a comprehensive explanation of subsequent care without radiotherapy. Some patients understood that refusal was theoretically possible but did not perceive it as a realistic choice in the clinical encounter. The study therefore identified a gap between formal patient autonomy and the practical experience of decision-making.
  • Receiving information did not necessarily prepare patients for the physical experience of radiotherapy. Participants described uncertainty about treatment positioning, skin tattoos, bladder and bowel preparation, and the degree of physical exposure or assistance required during pelvic treatment. Brachytherapy was particularly difficult for some patients to anticipate because of its invasive nature, positioning requirements, and potential psychological distress. These experiences affected dignity, body image, and perceived control during treatment.
  • Patients also described insufficient preparation for treatment-related side effects. Some perceived explanations of acute and late toxicity as overly reassuring or insufficiently specific, even when written materials had been provided. They reported that learning about potential adverse effects did not always translate into understanding their likely consequences for daily life, physical function, or personal relationships. Importantly, these were qualitative accounts of perceived communication gaps rather than independently verified instances of inadequate clinical disclosure.
  • The findings support ongoing consent conversations rather than a single information-delivery event. The authors emphasize providing adequate time, revisiting treatment choices, discussing alternatives and refusal, and preparing patients for the practical and long-term consequences of therapy. However, the interview sample was small and potentially subject to participation bias, and the study did not compare consent interventions or measure subsequent decisional regret. Its findings also reflect the NHS care environment and may not fully generalize to other healthcare systems.

CLINICAL TAKEAWAY

Formal informed consent does not necessarily mean patients feel prepared for gynecological radiotherapy or understand how treatment may affect their lives. These qualitative findings support treating consent as an ongoing, patient-centered discussion that addresses alternatives, practical treatment experiences, and meaningful long-term consequences. Further intervention studies are needed to determine which approaches improve patient understanding, preparedness, and decision quality.

SOURCE

Technical Innovations & Patient Support in Radiation Oncology

Browse more research Suggest a correction